These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 11858896

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Pap smear screening history of women with squamous cell carcinoma and adenocarcinoma of the cervix.
    Pak SC, Martens M, Bekkers R, Crandon AJ, Land R, Nicklin JL, Perrin LC, Obermair A.
    Aust N Z J Obstet Gynaecol; 2007 Dec; 47(6):504-7. PubMed ID: 17991118
    [Abstract] [Full Text] [Related]

  • 24. Screening frequency and atypical cells and the prediction of cervical cancer risk.
    Chen YY, You SL, Koong SL, Liu J, Chen CA, Chen CJ, Taiwan Cervical Cancer Screening Task Force.
    Obstet Gynecol; 2014 May; 123(5):1003-1011. PubMed ID: 24785853
    [Abstract] [Full Text] [Related]

  • 25. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
    Kim TJ, Kim HS, Park CT, Park IS, Hong SR, Park JS, Shim JU.
    Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049
    [Abstract] [Full Text] [Related]

  • 26. Endometrial adenocarcinoma with clinical evidence of cervical involvement: accuracy of diagnostic procedures, clinical course, and prognostic factors.
    Leminen A, Forss M, Lehtovirta P.
    Acta Obstet Gynecol Scand; 1995 Jan; 74(1):61-6. PubMed ID: 7856435
    [Abstract] [Full Text] [Related]

  • 27. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
    Seki T, Tanabe H, Nagata C, Suzuki J, Suzuki K, Takano H, Isonishi S, Ochiai K, Takakura S, Okamoto A.
    Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Lack of any impact of histopathology type on prognosis in patients with early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Teke F, Yoney A, Teke M, Inal A, Urakci Z, Eren B, Zincircioglu SB, Buyukpolat MY, Ozer A, Isikdogan A, Unsal M.
    Asian Pac J Cancer Prev; 2014 Jan; 15(6):2815-9. PubMed ID: 24761906
    [Abstract] [Full Text] [Related]

  • 34. Value of histiocyte detection in Pap smears for predicting endometrial pathology. An institutional experience.
    Nassar A, Fleisher SR, Nasuti JF.
    Acta Cytol; 2003 Jan; 47(5):762-7. PubMed ID: 14526675
    [Abstract] [Full Text] [Related]

  • 35. Pap smear, an important screening tool to detect precancerous stage of carcinoma of cervix.
    Haider G, Parveen Z, Anjum F, Munir A.
    J Ayub Med Coll Abbottabad; 2013 Jan; 25(1-2):26-7. PubMed ID: 25098046
    [Abstract] [Full Text] [Related]

  • 36. Outcome analysis of cervical adenosquamous carcinoma compared with adenocarcinoma.
    Chen JL, Cheng JC, Kuo SH, Chen CA, Lin MC, Huang CY.
    Acta Obstet Gynecol Scand; 2012 Oct; 91(10):1158-66. PubMed ID: 22497449
    [Abstract] [Full Text] [Related]

  • 37. Screening History Among Women with Invasive Cervical Cancer in an Academic Medical Center: Will We Miss Cancers Following Updated Guidelines?
    Nitschmann C, May T, Mirkovic J, Feldman S.
    J Womens Health (Larchmt); 2016 Aug; 25(8):826-31. PubMed ID: 26859535
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.